PAM
Princeton Alpha Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-11,011
| Closed | -$48K | – | 773 |
|
|
2016
Q2 | $48K | Buy |
+11,011
| New | +$48K | 0.01% | 745 |
|
|
2016
Q1 | – | Sell |
-21,014
| Closed | -$330K | – | 751 |
|
|
2015
Q4 | $330K | Buy |
+21,014
| New | +$330K | 0.06% | 466 |
|
|
2015
Q2 | – | Sell |
-8,788
| Closed | -$245K | – | 724 |
|
|
2015
Q1 | $245K | Sell |
8,788
-14,326
| -62% | -$399K | 0.05% | 537 |
|
|
2014
Q4 | $422K | Buy |
23,114
+7,513
| +48% | +$137K | 0.12% | 277 |
|
|
2014
Q3 | $202K | Buy |
+15,601
| New | +$202K | 0.05% | 562 |
|